PDMI Paradigm Medical Industries Inc (CE)

Paradigm Medical Industries, Inc. (OTCBB: PDMI) announced today plans to initiate important steps to reorganize and reposition the Company. These plans include engineering improvements to many of its products and a critical assessment of its operations efforts. It will concentrate its efforts on capitalizing on the evolving needs of its customers within the ophthalmic market. The Company is launching new branding efforts for Paradigm Medical Industries in the global and domestic markets. With the creation of a new management team to restructure the future of the Company, Paradigm Medical intends to better define itself and begin the development of new and innovative products for the Glaucoma and ultrasound microscopy fields.

According to Glaucoma Research Foundation, statistics show that over 4 million Americans have glaucoma but only half of those know they have it, and around 65 million have glaucoma worldwide. In the United States alone, approximately 120,000 individuals are blind from glaucoma, accounting for 9% to 12% of all cases of blindness. Glaucoma is the second leading cause of blindness in the world, according to the World Health Organization. Glaucoma is not curable, and vision lost cannot be regained. With medication and/or surgery, it is possible to halt further loss of vision. Since glaucoma is a chronic condition, it must be monitored for life.

"The epidemic is real and growing," said Paradigm Medical President, Stephen Davis. "Our goal is to become the leader in Glaucoma diagnosis, monitoring and understanding in the ophthalmic industry. Paradigm has had its bumps and detours over the last few years; however, those days are finally past! We have brought ourselves back and are on track to come out strong with new innovative products that will help fight and control the glaucoma epidemic."

About Paradigm Medical Industries, Inc.

Headquartered in Salt Lake City, Utah, Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes cutting edge, new innovative products in the diagnostic ultrasound and early glaucoma detection markets. Paradigm has the only patented technology utilizing Photon(TM) laser for cataract removal. The Company is poised to capture a niche market within the Glaucoma and ultrasound microscopy fields. Paradigm Medical Industries markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States, as well as internationally.

For more information, please visit: www.paradigm-medical.com

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.

Contact: Paradigm Medical Industries, Inc. Stephen Davis President 801-977-8970 www.paradigm-medical.com